RE: The Final Countdown18 Apr 2023 16:46
The tumours in phase 1a don't respond to dox. Phase 1a is all about safety.
Phase 1b will work with tumours that respond to dox.
The curveball is Avacta's American clinical sites will be dosing soft tissue sarcoma patients. immediately. Avacta to concentrate on STS.
But..